EffRx Pharmaceuticals ^Company

EffRx Pharmaceuticals is a Swiss pharmaceutical company that develops and sells prescription medications for specialty indications, with a focus on musculoskeletal, genitourinary, and rare diseases. Their business model is centered around providing clinical and commercial value propositions for physicians, payers, and patients. Their lead product, Binosto\xae, is used to treat osteoporosis and is marketed in several countries. EffRx has a global network of partners to distribute their products and received an orphan drug designation from the FDA for a pipeline compound in 2014. The company has an experienced board of directors and management team with a proven track record in pharmaceutical and biotechnology companies.